1-2 of 2
Bing Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Synthetic Lethal Metabolic Targeting of Androgen-Deprived Prostate Cancer Cells with Metformin

Bing Yang, Shivashankar Damodaran, Tariq A. Khemees, Mikolaj J. Filon, Adam Schultz, Joseph Gawdzik, Tyler Etheridge, Dmitry Malin, Kyle A. Richards, Vincent L. Cryns, David F. Jarrard
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (11): 2278–2287.
https://doi.org/10.1158/1535-7163.MCT-19-1141
Published: 03 November 2020
View article titled, Synthetic Lethal Metabolic Targeting of Androgen-Deprived Prostate Cancer Cells with Metformin
Open the PDF for Synthetic Lethal Metabolic Targeting of Androgen-Deprived Prostate Cancer Cells with Metformin in another window
Includes: Supplementary data
Journal Articles

Abstract B167: Identifying first in human (FIH) doses and schedule of U3‐1287 (AMG 888), a fully human anti‐HER3 mAb, based on preclinical pharmacokinetic (PK), pharmacodynamic (PD) and efficacy data

Peggy Lum, Juan Jose Perez Ruixo, Selam Ogbagabriel, Sameer Doshi, Alin Chen, Bing Bing Yang, Thore Hettman, Robert Radinsky, Dan Freeman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B167.
https://doi.org/10.1158/1535-7163.TARG-09-B167
Published: 10 December 2009
View article titled, Abstract B167: Identifying first in human (FIH) doses and schedule of U3‐1287 (AMG 888), a fully human anti‐HER3 mAb, based on preclinical pharmacokinetic (PK), pharmacodynamic (PD) and efficacy data